SIGN UP
LOG IN
Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Benzinga·06/24/2025 10:38:26
Listen to the news
Shares of Nektar Therapeutics (NASDAQ:NKTR) rose sharply in today's pre-market trading after the company announced it will release top-line data from the 16-week induction period in the ongoing global Phase 2b REZOLVE-AD clinical trial of investigational rezpegaldesleukin on June 24, 2025.
Nektar Therapeutics shares jumped 30.3% to $12.44 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- iBio, Inc. (NASDAQ:IBIO) surged 55.8% to $1.11 in pre-market trading after the company announced it will host a conference call to review its advances in obesity and cardiometabolic disease treatments and announce a third target in the AstralBio Collaboration in addition to Myostatin and Activin E.
- Plus Therapeutics, Inc. (NASDAQ:PSTV) gained 27.7% to $0.2354 in pre-market trading after falling 5% on Monday.
- Korea Electric Power Corporation (NYSE:KEP) gained 20.1% to $12.44 in pre-market trading.
- Liminatus Pharma, Inc. (NASDAQ:LIMN) rose 18.5% to $23.74 in pre-market trading after jumping over 38% on Monday.
- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) jumped 17.2% to $0.3089 in pre-market trading after gaining 7% on Monday. Adial Pharmaceuticals recently announced the pricing of a $3.6 million offering.
- Surf Air Mobility Inc. (NASDAQ:SRFM) climbed 16.2% to $2.23 in pre-market trading.
- Rezolve AI PLC (NASDAQ:RZLV) gained 11.8% to $2.28 in pre-market trading. Rezolve AI shares gained around 6% on Monday after the company announced it will join the Russell 2000 and Russell 3000 indexes
- WF Holding Limited (NASDAQ:WFF) rose 9.2% to $7.10 in pre-market trading after dipping 6% on Monday.
- Teladoc Health, Inc. (NYSE:TDOC) gained 5.8% to $8.36 in pre-market trading. Teladoc shares surged over 14% on Monday after Citron Research made comments about the company on social media.
Losers
- Upexi, Inc. (NASDAQ:UPXI) shares tumbled 62.3% to $3.77 in pre-market trading after gaining 8% on Monday.
- Maase Inc. (NASDAQ:MAAS) shares fell 52.4% to $4.73 in pre-market trading after jumping over 268% on Monday.
- DeFi Development Corp. (NASDAQ:DFDV) dipped 39.2% to $15.06 in pre-market trading. DeFi Development rescheduled release of shareholder letter and business update call to July.
- Robin Energy Ltd. (NASDAQ:RBNE) declined 26.7% to $4.91 in pre-market trading after gaining 9% on Monday.
- Indonesia Energy Corporation Limited (NASDAQ:INDO) dipped 25.4% to $3.64 in pre-market trading after falling around 4% on Monday.
- TMD Energy Limited (NYSE:TMDE) fell 23.8% to $1.76 in pre-market trading after jumping 30% on Monday.
- Impact BioMedical Inc. (NYSE:IBO) declined 22.1% to $1.16 in pre-market trading. Impact BioMedical shares jumped 345% on Monday after the company announced a limited merger and share exchange agreement with Dr Ashleys.
- Nine Energy Service, Inc. (NYSE:NINE) fell 21.7% to $0.9160 in pre-market trading after jumping around 14% on Monday.
- Regencell Bioscience Holdings Limited (NASDAQ:RGC) fell 8.8% to $21.62 in pre-market trading after dipping 38% on Monday.
- Sasol Limited (NYSE:SSL) fell 8.2% to $4.69 in pre-market trading.
Now Read This:
Photo via Shutterstock
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.